NEW ON THE MARKET
Inactivated zoster vaccine SHINGRIX
Me too: SGLT2 inhibitor ertugliflozin (in STEGLUJAN)
a-t READERS QUESTIONS AND COMMENTS
Statins: “treat-to-target” or “fire-and-forget” strategies – What is new?
Parecoxib (DYNASTAT) against postoperative pain?
Confirmed: no analgesics alone for uncomplicated cystitis
CURRENT ADR NETWORK REPORT
Hearing loss with secukinumab (COSENTYX)? free article
Hypersensitivity reactions to flurbiprofen throat drugs
Dietary supplement kratom: FDA warns against fatal risks
Increased risk of secondary cancer with denosumab (XGEVA)
Neural tube defects with dolutegravir (TIVICAY, in TRIUMEQ)
© 2018 arznei-telegramm